Today: 4 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Hims & Hers stock price slides again as Novo Nordisk lawsuit tightens the screws on Wegovy copies

Hims & Hers stock price slides again as Novo Nordisk lawsuit tightens the screws on Wegovy copies

Hims & Hers Health shares fell 5.6% to $18.25 Tuesday after Novo Nordisk filed a U.S. patent lawsuit seeking to block sales of compounded versions of its Wegovy weight-loss drug. The FDA has said semaglutide is no longer in shortage, tightening rules on compounding. Hims pulled its $49 compounded semaglutide pill days after launch. Investors await Hims’ earnings on Feb. 23.
10 February 2026
···
Booking Holdings stock price rebounds on Gordon Haskett upgrade as BKNG eyes Feb. 18 earnings

Booking Holdings stock price rebounds on Gordon Haskett upgrade as BKNG eyes Feb. 18 earnings

Booking Holdings shares climbed nearly 3% Tuesday after Gordon Haskett upgraded the stock to “buy” with a $5,440 price target. The rebound follows a 5% drop Monday; shares remain well below their July 2025 high. Investors await Booking’s quarterly results and conference call on Feb. 18. Trading volume was above average, with the stock lagging travel peers the previous session.
10 February 2026
··
Flutter Entertainment stock price today: FLUT edges up as UBS cuts target and prediction markets loom

Flutter Entertainment stock price today: FLUT edges up as UBS cuts target and prediction markets loom

Flutter shares rose 0.6% to $155.48 Tuesday morning after UBS cut its price target to $300 but kept a buy rating. The move comes as investors track competition from prediction markets and await Flutter’s fourth-quarter results on Feb. 26. Massachusetts regulators are challenging prediction markets, with Polymarket suing the state attorney general. Flutter’s stock recently ended an eight-week losing streak.
10 February 2026
·
CoreWeave stock slips as lawsuit notices and insider-sale filing hit a hot trade

CoreWeave stock slips as lawsuit notices and insider-sale filing hit a hot trade

CoreWeave shares fell 2% to $94.84 Tuesday, reversing part of Monday’s gain, after a class-action notice and insider-related SEC filing circulated. An entity linked to co-founder Brannin McBee filed to sell shares, while law firms urged investors to join a proposed lawsuit over infrastructure delays. Investors await CoreWeave’s Feb. 26 earnings for updates on capacity and funding. The broader tech sector was steady.
10 February 2026
Lumentum stock price drops as rally cools — here’s what traders watch next

Lumentum stock price drops as rally cools — here’s what traders watch next

Lumentum shares fell 2.4% to $563.33 Tuesday morning after a strong prior session, swinging between $531 and $579 as major indexes edged up. The drop follows a recent rally tied to AI and cloud data-center spending. Last week, Lumentum reported Q2 revenue of $665.5 million and forecast Q3 revenue up to $830 million. Management will appear at tech conferences on Feb. 26 and March 2.
10 February 2026
·
Exxon Mobil stock slips from fresh high as oil steadies and U.S. data looms

Exxon Mobil stock slips from fresh high as oil steadies and U.S. data looms

Exxon Mobil shares slipped 0.5% to $150.49 Tuesday morning after hitting a 52-week high at $151.21 on Monday. Oil prices were little changed, with Brent at $69.31 and WTI at $64.48 as traders watched U.S.-Iran tensions and awaited U.S. inventory data. Chevron and ConocoPhillips also traded lower. Investors are focused on Exxon's Feb. 20 investor update and upcoming U.S. economic reports.
10 February 2026
···
Eli Lilly stock price dips as $2.4 billion Orna deal and China pact grab attention

Eli Lilly stock price dips as $2.4 billion Orna deal and China pact grab attention

Eli Lilly shares fell 0.9% to $1,035.54 Tuesday morning after new deals in cell therapy and China drug development. The company agreed to buy Orna Therapeutics for up to $2.4 billion and struck a collaboration with Innovent Biologics. Investors weighed increased pipeline spending as competition in obesity drugs intensified. Attention turns to an upcoming FDA decision on Lilly’s oral obesity pill.
10 February 2026
··
Palo Alto Networks (PANW) stock nudges higher as Nasdaq flags Feb 11 close for CyberArk deal

Palo Alto Networks (PANW) stock nudges higher as Nasdaq flags Feb 11 close for CyberArk deal

Palo Alto Networks shares rose 0.5% to $166.88 Tuesday as Nasdaq set a tentative Feb. 11 close for its $25 billion merger with CyberArk. CyberArk stock will be halted after-hours Tuesday and suspended Feb. 12. Palo Alto reports earnings Feb. 17, with investors watching for integration plans. Cybersecurity stocks traded higher across the board.
10 February 2026
····
Netflix stock price jumps 3% as Paramount ups the pressure in Warner Bros battle

Netflix stock price jumps 3% as Paramount ups the pressure in Warner Bros battle

Netflix shares rose 3.1% to $84.00 after Paramount raised its bid for Warner Bros. Discovery and offered to cover a $2.8 billion breakup fee tied to Netflix’s deal. Paramount extended its tender offer deadline to March 2 and added a “ticking fee” for WBD holders if closing is delayed past 2026. Warner Bros. Discovery shares gained 1.8%. Traders are watching the antitrust review and the new timeline.
10 February 2026
···
Oracle stock price today jumps again as OpenAI-linked upgrade powers ORCL rebound

Oracle stock price today jumps again as OpenAI-linked upgrade powers ORCL rebound

Oracle shares rose 3.4% to $161.92 Tuesday after D.A. Davidson upgraded the stock, citing upside from OpenAI-linked cloud demand and new AI features in Oracle Fusion apps. Analyst Gil Luria set a $180 target, noting Oracle’s 15% stake in a U.S. TikTok venture and potential new OpenAI funding. The rally follows a 9.6% jump Monday. Oracle’s debt load and heavy AI infrastructure spending remain in focus.
10 February 2026
·
AppLovin stock price rises again after CapitalWatch apology, with APP earnings up next

AppLovin stock price rises again after CapitalWatch apology, with APP earnings up next

AppLovin shares rose about 3% to $474.31 Tuesday morning, extending a rebound after CapitalWatch retracted parts of its allegations about shareholder Tang Hao. The stock jumped 13% Monday after the correction and apology. Jefferies called recent fears “overblown” and reaffirmed a buy rating. AppLovin reports quarterly results after the bell on Feb. 11.
10 February 2026
···
Strategy Inc stock slips as Saylor vows quarterly bitcoin buys and debt refinancing

Strategy Inc stock slips as Saylor vows quarterly bitcoin buys and debt refinancing

Strategy Inc shares fell 1.6% to $136.29 Tuesday after a filing showed it sold stock to fund a $90 million bitcoin purchase last week. The company bought 1,142 bitcoin at an average $78,815 each and now holds 714,644 tokens. Executive chairman Michael Saylor said Strategy will keep buying bitcoin every quarter and refinance debt if needed. Bitcoin hovered near $69,240, down 0.4%.
10 February 2026
····
Sandisk stock drops again as AI hardware trade turns shaky — what investors watch next

Sandisk stock drops again as AI hardware trade turns shaky — what investors watch next

Sandisk shares fell 4.2% to $558.96 in early New York trading Tuesday, extending Monday’s drop as storage and memory stocks weakened. Western Digital dropped 5.2% and Micron lost 2.2%. Investors weighed AI demand signals, rising memory prices, and news that Samsung will soon mass-produce next-generation HBM4 chips. Attention is turning to U.S. jobs and inflation data and Nvidia’s Feb. 25 earnings.
10 February 2026
····
1 … 54 55 56 57 58 … 685
Go toTop